Top research peptides for fat loss, metabolic optimization, and body composition improvement.
Weight loss peptides represent one of the most rapidly evolving areas of research, driven by the success of GLP-1 receptor agonists. Several peptide classes have demonstrated significant fat loss effects through appetite suppression, metabolic rate enhancement, and direct lipolytic mechanisms.
Research Disclaimer: All content on this page is for educational and research purposes only. These compounds are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide protocol.
Retatrutide is a triple agonist (GIP + GLP-1 + glucagon) that has shown the highest fat loss of any peptide in clinical trials — up to 24% body weight reduction at 48 weeks. The glucagon component adds direct lipolytic activity beyond what GLP-1 alone provides.
Tirzepatide is a dual GIP/GLP-1 agonist with robust clinical data showing 15–22% body weight reduction. It is FDA-approved as Mounjaro/Zepbound and has the strongest human evidence base of any weight loss peptide.
Semaglutide is a GLP-1 receptor agonist FDA-approved for weight loss (Wegovy) and diabetes (Ozempic). It produces 10–15% body weight reduction and has extensive long-term safety data.
MOTS-c is a mitochondria-derived peptide that activates AMPK and improves insulin sensitivity. It promotes fat oxidation and has shown anti-obesity effects in preclinical models, particularly for metabolic syndrome.
Retatrutide has shown the highest fat loss in clinical trials (up to 24% body weight), followed by tirzepatide (15–22%) and semaglutide (10–15%). All three are GLP-1-based compounds.
GLP-1 receptor agonists reduce appetite by slowing gastric emptying and acting on hypothalamic satiety centers. They also improve insulin sensitivity and reduce food reward signaling. The result is significantly reduced caloric intake.
Semaglutide is a GLP-1 mono-agonist. Tirzepatide adds GIP receptor agonism, which enhances fat cell insulin sensitivity and produces greater weight loss. Retatrutide adds glucagon agonism on top of both, producing the highest fat loss currently observed.
Purgo Labs provides pharmaceutical-grade research peptides with third-party COAs. Use code HEALTH for 15% off your first order.
Visit Purgo LabsMedical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.